EXEL240920C26000
- 1.00
- +0.10+11.11%
Exelixis Newsroom
Exelixis Price Target Announced at $30.00/Share by UBS
UBS Initiates Exelixis(EXEL.US) With Hold Rating, Announces Target Price $30
Exelixis Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Exelixis, Maintains $29 Price Target
H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $29
Citi Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $31
Exelixis (EXEL) Gets a Hold From Stifel Nicolaus
Wells Fargo Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $32
H.C. Wainwright Maintains Exelixis(EXEL.US) With Buy Rating, Maintains Target Price $29
Exelixis (EXEL) Stock Buy Rating Affirmed on Promising Subgroup Data and Market Opportunity in MCRPC Treatment
BofA Securities Maintains Exelixis(EXEL.US) With Buy Rating
Bank of America Securities Sticks to Its Buy Rating for Exelixis (EXEL)
Exelixis (EXEL) Receives a Buy From Wells Fargo
Exelixis: Balancing Strong Financials With Operational Challenges in Berens's Hold Rating
Exelixis Price Target Raised to $29.00/Share From $27.00 by JMP Securities
RBC Capital Reiterates Outperform on Exelixis, Maintains $27 Price Target
Exelixis Analyst Ratings
Exelixis Buy Rating Affirmed on Strong Q2 Performance and Promising Pipeline Prospects
Exelixis's Strong Q2 Financials and Strategic Pipeline Prompts a Buy Rating
Barclays Reaffirms Their Hold Rating on Exelixis (EXEL)